Preliminary Final Report
Released
Released
Announcement PDF
CLEARVUE TECHNOLOGIES LIMITED AND ITS CONTROLLED ENTITIES
ABN 45 071 397 487
Appendix 4E
1. Company details
Name of entity: ClearVue Technologies Limited
ABN: 45 071 397 487
Reporting period: For the year ended 30 June 2026
Previous period: For the year ended 30 June 2025
2. Results for announcement to the market $
Revenues from ordinary activities down 35% to 161,264
Loss from ordinary activities after tax attributable to the owners of
Clearvue Technologies Limited down 5% to 10,994,087
Loss for the year attributable to the owners of Clearvue Technologies
Limited down 5% to 10,994,087
Dividends
No dividend has been declared or paid for the year ended 30 June 2026(30 June 2025: $nil).
Brief Explanation of Results
For fiscal year 2025 ClearVue revenue from ordinary activities increased by 553% to $249,925. Net loss after tax was cut
by 7% to 11,584,706.Fiscal year 2026 was a year of comprehensive operational reset followed by the most significant
product certification programme in the Company's history. The financial year opened with a full refresh of the Board and
executive team and closed with a certified product suite, first project wins in Europe and with a global technology brand,
entry into two new manufacturing markets, and a materially reduced cost base. The restructuring programme removed
approximately $6.9 million in annualised costs and delivered a 52.7% reduction in cash burn against the prior
corresponding period. In the first quarter of fiscal year 2026 ClearVue executed an equity placement raising approximately
$4.6 million, and in June 2026 announced a further capital raising of approximately $5.25 before costs via a equity
placement raising.
Product Advancements and Announcements:
• July 2025: ClearVue partnered with LandVac, a subsidiary of LandGlass, to co-develop a vacuum-insulated solar
glazing range comprising Vision Glass, skylights, spandrel and cladding products.
• September 2025: ClearVue announced its Gen3 Solar Vision Glass, with early independent testing by the Solar
Energy Research Institute of Singapore demonstrating more than 66% higher energy output per square metre.
ClearVue also reported over 50% shorter processing time and an approximately 50% reduction in production cost.
• October 2025: ClearVue announced a prefabricated carpark solution in which the ClearVue-Helios panels form the
roof structure rather than sitting on it, delivering cost advantages over traditional rooftop solar alternatives.
• January 2026: ClearVue implemented Tunnel Oxide Passivated Contact (TOPCon) cells across its Solar Spandrel
and Solar Cladding range, delivering a 2% efficiency improvement equivalent to 5 to 7 watts per square metre at
no additional cost, improving customer payback periods.
• March 2026: ClearVue and manufacturing partner Helios Power achieved global IEC 61730 (2023) and IEC 61215
(2021) certification for their jointly developed metal-backed rooftop and car park solar panels, and subsequently
commenced the Australian Clean Energy Council (CEC) certification process.
• May 2026: ClearVue’s proprietary Thermal Management Junction Box achieved IEC 62790 certification from TÜV
SÜD, validating its safety and suitability for enclosed solar façade applications.
• June 2026: ClearVue’s Gen3 Solar Vision Glass passed EN 1279-5:2018 testing, confirming the long-term sealing
performance and durability of its insulating glass unit configuration.
• June 2026: ClearVue’s complete double-glass product range achieved Grade A classification under AS/NZS
2208:2023. The certification covered Vision Glass, Solar Skylight, Solar Balustrade, Solar Cladding and Solar
Spandrel.
CLEARVUE TECHNOLOGIES LIMITED AND ITS CONTROLLED ENTITIES
ABN 45 071 397 487
Appendix 4E
Strategic Partnerships:
• July 2025: ClearVue signed a non-binding MOU with LandVac, a LandGlass subsidiary, to develop, manufacture
and commercialise solar vacuum-insulated glazing. The proposed products would be co-branded and distributed
through both companies’ networks.
• July 2025: ClearVue entered a collaboration agreement with erbas | erbas SUSTAIN to accelerate
commercialisation, leveraging ERBAS's expertise in sustainable building design to drive new project opportunities
and industry engagement.
• November 2025: License partner Concept Business Group agreed to reclad two 10-storey South African towers
with ClearVue's Vision Glass, Skylight and Cladding, in a project expected to exceed A$1 million, targeting over
40% of each building's energy needs.
• March 2026: ClearVue expanded its strategic manufacturing and R&D partnership with Helios Power for metal-
backed rooftop and carpark solar panels. Their continuing program focused on installation efficiency, product
performance, electrical safety, lower installation costs and international certification.
• May 2026: ClearVue and the University of Melbourne were awarded an A$280,000 Australian Research Council
Linkage Grant. The three-year research program will investigate new techniques for increasing solar electricity
generation from transparent glass.
• May 2026: ClearVue reported a new Hong Kong office and five-project regional pipeline developed through its
LandVac relationship, with testing underway on two projects. ClearVue and InvestHK also began developing a
PPA-style model intended to reduce building owners’ upfront costs.
License Partner Agreements: .
• August 2025: ClearVue signed a five-year agreement with architectural glass leader Emirates Glass to
manufacture and distribute glazing products featuring ClearVue innovations, strengthening the Company's position
in the United Arab Emirates alongside Alutec in Qatar.
• November 2025: ClearVue signed a three-year License Partner Agreement with Kukyoung Glass and Metal Co.,
Ltd. The agreement authorised Kukyoung to market and deploy ClearVue Solar Façade technology in South Korea
and supported joint research and product development.
• May 2026: ClearVue entered the Indian market through a manufacturing and distribution agreement with Aria
Glass Industries Private, part of the Aria Holding group. The agreement grants Aria Glass the right to manufacture
ClearVue's products in India and to distribute them domestically and internationally on a non-exclusive basis, for
an initial term of three years with options to extend. India's construction sector was valued at more than US$1
trillion in 2025. The agreement complements ClearVue's existing relationship with Alutec across the Middle East.
Noteworthy Projects:
• September 2025: Double-glazed solar skylight units were delivered to the World Bank Administration Building in
Abuja, Nigeria for installation. Compatibility testing was completed at Sydney House, formerly City Tattersalls Club,
in Sydney, Australia, with the Company engaging on cabling and electrical design.
• November 2025: Concept Business Group submitted a purchase order exceeding A$1 million to reclad two South
African towers with ClearVue Vision Glass, Solar Skylights and Solar Cladding. ClearVue projected the façades
could supply over 40% of the buildings’ energy requirements.
• March 2026: The construction phase of the pure black Solar Spandrel installation at Enex100, 100 St Georges
Terrace in Perth, Australia was completed. The project moved into close-out, with commissioning and grid
integration scheduled for the building's annual shutdown period.
• March 2026: The Prefabulous Net Zero Cabin at Inverloch, Victoria, featuring ClearVue Gen2 Solar Vision Glass,
was delivered to its final client location ready for rooftop installation of 28 ClearVue-Helios panels with a combined
system capacity of 16.52 kWp, acting as a second skin, waterproofing and extending the life of the roof material.
• March 2026: ClearVue commenced project-specific measurement and verification testing in connection with two
large-scale commercial building opportunities in Asia, measuring the thermal performance and energy generation
of Gen3 Solar Vision Glass against conventional and incumbent glazing under real-world conditions, and
commenced project-specific local certification for a residential tower in the Middle East.
• May 2026: ClearVue secured its first European commercial project at the Rio Business Centre in Paphos, Cyprus.
The approximately A$305,000 contract covered more than 800 m² of BIPV glazing and framing, with an estimated
capacity of 169 kW and forecast annual generation of approximately 139 MWh.
• May 2026: ClearVue received a non-binding Letter of Intent confirming it as the successful tenderer for Canva’s
new Sydney headquarters. The proposed installation covered approximately 660 m² of Solar Skylights, Solar
Balustrades and rooftop solar systems
CLEARVUE TECHNOLOGIES LIMITED AND ITS CONTROLLED ENTITIES
ABN 45 071 397 487
Appendix 4E
Corporate and Governance:
• August 2025: Douglas Hunt joined ClearVue’s Board as Managing Director while serving as CEO. Theresa Smits
was appointed Non-Executive Chairperson following Victor Rosenberg’s transition from Chair to Non-Executive
Director.
• November 2025: Founder Victor Rosenberg retired from the Board at the Annual General Meeting held on 28
November 2025.
• December 2025: Liang Ji, formerly a Principal Engineer at Underwriters Laboratories and a contributor to
international photovoltaic standards, was appointed a Non-Executive Director.
• March 2026: Andrew Lau, Director of ESG Advisory at Colliers Asia, was appointed a Non-Executive Director,
bringing more than 22 years of sustainability and carbon reduction experience across Asian markets.
Research, Development and Government Engagement:
• November 2025: ClearVue received $881,270.85 under the Australian Government Research and Development
Tax Incentive program and retired its short-term loan of $409,174 from Radium Capital that was secured by the
rebate.
• March 2026: ClearVue made a written submission to, and gave evidence at the public hearing of, the Victorian
Parliament Legislative Assembly Environment and Planning Committee inquiry into renewable and affordable
energy for apartments and other multi-unit dwellings.
Capital Management:
• October 2025: ClearVue completed an equity placement raising approximately $4.6 million, supported by
institutional and other investors internationally and domestically, co-lead managed by RM Capital and Spark+.
• March 2026: ClearVue established a A$3 million facility with Riverfort Global Opportunities PCC Ltd at 8% interest,
secured over its R&D tax incentive. At 30 June 2026, A$1.9 million was drawn and A$1.1 million remained
available.
• June 2026: ClearVue announced an approximately A$6 million Placement and Share Purchase Plan. It received
approximately A$4.8 million before costs by issuing 42,054,348 shares at A$0.115. Proceeds supported
certification, ERP systems, marketing, intellectual property and international business development.
Highlights:
• Operational Reset and Cost Discipline: A comprehensive restructuring programme reduced annualised costs
and delivered a reduction in cash burn against the prior corresponding period, with all restructuring tail payments
completed during the year, providing a leaner cost base from which to pursue commercialisation.
• Product Certification and Market Credibility: The most significant certification programme in the Company's
history was delivered, spanning AS/NZS 2208:2023, EN 1279-5:2018, IEC 62790, IEC 61730 and IEC 61215,
confirming that ClearVue's energy-generating products perform to the same standards expected of conventional
high-quality architectural glazing and removing risk from customer specification decisions.
• Geographic Expansion: ClearVue secured its first European project in Cyprus, entered the Indian manufacturing
market through Aria Glass Industries, strengthened its Middle East position through Emirates Glass, and
established an operating presence in Hong Kong with a five-project regional pipeline.
• Commercial Validation: Selection for the new Sydney headquarters of Canva, one of the world's leading
technology companies, together with the Concept Business Group reclad project in South Africa, provided
reference projects for the corporate, commercial and global retrofit markets.
• Commercialisation Pipeline: The project pipeline grew beyond 80 projects with approximately 60 full proposals
submitted, supported by new customer relationship management software, expanded business development
capability across Australia, Hong Kong and Europe, and approximately 15 new project enquiries per month by year
end.
• R&D Investment and Validation: The Australian Research Council Linkage Grant with The University of
Melbourne, receipt of the Research and Development Tax Incentive, and progression of the world-first full-scale
façade fire testing programme underpin the Company's long-term technology leadership in BIPV solutions.
No other significant changes occurred in the nature of the Company's activities during the financial year.
The loss for the consolidated entity after providing for income tax amounted to $10,994,087 (30 June 2025 $11,584,706).
CLEARVUE TECHNOLOGIES LIMITED AND ITS CONTROLLED ENTITIES
ABN 45 071 397 487
Appendix 4E
3. Net tangible assets
Reporting
period
Previous
period
Cents Cents
Net tangible assets per ordinary security 0.86 1.11
6. Audit qualification or review
Details of audit/review dispute or qualification (if any):
The financial statements are in the process of being audited.
7. Attachments
Details of attachments (if any):
The Preliminary Financial Report of ClearVue Technologies Limited for the year ended 30 June 2026 is attached.
8. Signed
__________________________ Date: 31 August 2026
Theresa Smits
Chair
4. Details of associates and joint venture entities
Name Country of Incorporation
Ownership Interest
2026 2025
ClearVue International Pty Ltd Australia 100% 100%
ClearVue USA Inc United States of America 100% 100%
ClearVue (Asia) Pte.Ltd Singapore 100% 100%
ClearVue Europe BV Netherlands 100% 100%
Clearvue Europe Holdings BV Netherlands 100% 100%
Opticrop (Israel) Ltd Israel 100% 100%
ClearVue Hong Kong Limited Hong Kong 100% NA
5. Details of entities over which control has been gained or lost during the period
NA
CLEARVUE TECHNOLOGIES LIMITED AND ITS CONTROLLED ENTITIES
ABN 45 071 397 487
Appendix 4E
CLEARVUE TECHNOLOGIES LIMITED
AND ITS CONTROLLED ENTITIES
ABN 45 071 397 487
Appendix 4E
Preliminary Financial Report
30 June 2026
CLEARVUE TECHNOLOGIES LIMITED AND ITS CONTROLLED ENTITIES
ABN 45 071 397 487
CONSOLIDATED STATEMENT OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME
FOR THE YEAR ENDED 30 JUNE 2026
1
Consolidated Consolidated
Note 30 Jun 2026 30 Jun 2025
$ $
Revenue from contracts with customers 161,264 249,925
Other income 924,509 910,041
1,085,773 1,159,966
Expenses
Consulting expense (2,504,232) (3,167,310)
Depreciation and amortisation expense (570,814) (524,998)
Employee benefits expense (2,703,862) (3,281,565)
Finance costs (83,073) (33,135)
Legal fees (493,144) (211,256)
Impairment (1,901,552) (786,363)
Material costs (561,915) (1,084,439)
Share-based payments expense 8 (94,301) (526,492)
Product Development testing (954,566) (364,186)
Travel expenses (568,064) (712,759)
Other expenses (1,644,337) (2,052,169)
(12,079,860) (12,744,672)
Loss before income tax (10,994,087) (11,584,706)
Income tax expense - -
Loss for the year (10,994,087) (11,584,706)
Other comprehensive income / (loss) - -
Total comprehensive loss for the year (10,994,087) (11,584,706)
Loss per share attributable to the owners of
the Company (cents)
Basic loss per share 9 (3.7) (4.5)
Diluted loss per share 9 (3.7) (4.5)
See accompanying notes to the consolidated financial statements
CLEARVUE TECHNOLOGIES LIMITED AND ITS CONTROLLED ENTITIES
ABN 45 071 397 487
CONSOLIDATED STATEMENT OF FINANCIAL POSITION
AS AT 30 JUNE 2026
2
Consolidated Consolidated
Note 30 Jun 2026 30 Jun 2025
$ $
ASSETS
Current Assets
Cash and cash equivalents 2 4,420,700 3,591,254
Trade and other receivables 3 905,953 1,009,027
Other assets 482,639 711,476
5,809,292 5,311,757
Non-Current Assets
Plant and equipment 429,169 525,210
Right of use asset 599,107 472,517
Intangible assets 4 4,354,327 6,052,189
Other assets 150,944 144,496
5,533,547 7,194,412
Total Assets 11,342,839 12,506,169
LIABILITIES
Current Liabilities
Trade and other payables 5 1,222,371 2,011,957
Lease liabilities 159,115 80,664
Borrowings 1,926,750 409,158
Provisions 120,330 241,319
3,428,566 2,743,098
Non-Current Liabilities
Lease liabilities 480,081 410,961
Provisions 64,086 101,875
544,167 512,836
Total Liabilities 3,972,733 3,255,234
Net Assets 7,370,106 9,250,235
EQUITY
Share capital 6 60,508,169 51,349,503
Share-based payments reserve 7 3,841,972 8,624,453
Accumulated losses (56,980,035) (50,723,721)
Total Equity 7,370,106 9,250,235
See accompanying notes to the consolidated financial statements
CLEARVUE TECHNOLOGIES LIMITED AND ITS CONTROLLED ENTITIES
ABN 45 071 397 487
CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 30 JUNE 2026
3
Share
Capital
Share-Based
Payments
Reserve
Accumulated
Losses Total
$ $ $ $
Balance at 1 July 2024 41,021,685 8,592,859 (39,545,637) 10,068,907
Loss for the year - - (11,584,706) (11,584,706)
Other comprehensive income - - - -
Total comprehensive loss for the year - - (11,584,706) (11,584,706)
Share based payments 88,278 99,410 - 187,688
Performance rights exercised - (134,863) 134,863 -
Options issued 338,805 338,805
Options exercised 3,392,900 (195,596) 195,596 3,392,900
Options expired - (76,162) 76,162 -
Ordinary shares issued 7,500,000 - - 7,500,000
Share issue costs (653,360) - - (653,360)
Balance at 30 June 2025 51,349,503 8,624,453 (50,723,721) 9,250,235
Loss for the year - - (10,994,087) (10,994,087)
Other comprehensive income - - - -
Total comprehensive loss for the year - - (10,994,087) (10,994,087)
Share based payments 469,240 - - 469,240
Performance rights issued - 254,015 - 254,015
Performance rights lapsed (4,320,000) 4,320,000 -
Options issued - 530,689 - 530,689
Options exercised 309,700 - - 309,700
Options expired - (1,247,185) 417,773 (829,412)
Ordinary shares issued 9,460,365 - - 9,460,365
Share issue costs (1,080,639) - - (1,080,639)
Balance at 30 June 2026 60,508,169 3,841,972 (56,980,035) 7,370,106
See accompanying notes to the consolidated financial statements
CLEARVUE TECHNOLOGIES LIMITED AND ITS CONTROLLED ENTITIES
ABN 45 071 397 487
CONSOLIDATED STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 30 JUNE 2026
4
Consolidated Consolidated
Note 30 Jun 2026 30 Jun 2025
$ $
Cash flows from operating activities
Receipts from customers and others 1,098,456 1,369,251
Payments to suppliers, employees and others (9,719,885) (10,653,467)
Interest received 22,412 52,342
Interest paid (83,073) -
Net cash (used in) operating activities (8,602,090) (9,231,873)
Cash flows from investing activities
Patents and trademarks expenditure (596,212) (1,241,998)
Leases asset expenditure (227,410) -
Purchase of plant and equipment (25,089) (62,436)
Net cash (used in) investing activities (848,711) (1,304,434)
Cash flows from financing activities
Options exercised 309,000 3,392,900
Ordinary shares issued 9,461,065 7,500,000
Share issue costs (750,408) (654,440)
Loan proceeds 2,024,334 409,159
Loan repayments (806,743) -
Borrowings leases 227,410 -
Lease payments (79,840) (75,396)
Net cash from financing activities 10,384,818 10,572,224
Net (decrease) in cash and cash equivalents 854,017 35,917
Effects of currency translation on cash (24,571) 852
Cash and cash equivalents at beginning of year 3,591,254 3,554,485
Cash and cash equivalents at end of year 4,420,700 3,591,254
See accompanying notes to the consolidated financial statements
CLEARVUE TECHNOLOGIES LIMITED AND ITS CONTROLLED ENTITIES
ABN 45 071 397 487
NOTES TO CONSOLIDATED PRELIMINARY FINANCIAL REPORT
FOR THE YEAR ENDED 30 JUNE 2026
5
These notes form an integral part of and should be read in conjunction with the accompanying financial report:
1. BASIS OF PREPARATION
This preliminary financial report has been prepared in accordance with Australian Securities Exchange Listing
Rules as they relate to the Appendix 4E and in accordance with the recognition and measurement
requirements of the Australian Accounting Standards, other authoritative pronouncements of the Australian
Accounting Standards Board, Urgent Issues Group Interpretations and the Corporations Act 2001.
As such, this preliminary financial report does not include all the notes of the type included in an annual
financial report and accordingly, should be read in conjunction with the annual report for the year ended 30
June 2024 and with any public announcement made by Clearvue Technologies Limited during the period in
accordance with the continuous disclosure requirements of the Corporations Act 2001.
The principal accounting policies adopted in the preparation of the financial report are consistent with those of
the previous financial year.
2. CASH AND CASH EQUIVALENTS
Consolidated
30 Jun 2026
$
Consolidated
30 Jun 2025
$
Cash and cash equivalents 4,420,700 3,591,254
3. TRADE AND OTHER RECEIVABLE
Consolidated
30 Jun 2026
$
Consolidated
30 Jun 2025
$
Trade receivables 53,440 140,740
R&D rebate receivable 852,513 868,287
905,953 1,009,027
CLEARVUE TECHNOLOGIES LIMITED AND ITS CONTROLLED ENTITIES
ABN 45 071 397 487
NOTES TO CONSOLIDATED PRELIMINARY FINANCIAL REPORT
FOR THE YEAR ENDED 30 JUNE 2026
6
4. INTANGIBLE ASSETS
Consolidated
30 Jun 2026
$
Consolidated
30 Jun 2025
$
Patents and trademarks 2,107,595 3,666,079
Development asset 2,246,732 2,386,110
4,354,327 6,052,189
Patents and trademarks
Cost 6,142,709 5,546,497
Less impairment (2,678,915) (786,363)
Less accumulated amortisation (1,347,199) (1,094,055)
Carrying amount 2,107,595 3,666,079
Cost
Balance at 1 July 5,546,497 4,304,500
Additions1 596,212 1,241,997
Balance at 30 June 6,142,709 5,546,497
Accumulated amortisation
Balance at 1 July 1,094,055 861,391
Amortisation for the year 253,144 232,664
Balance at 30 June 1,347,199 1,094,055
Carrying amount at 30 June 2,107,595 3,666,079
Development asset
Cost 2,787,573 2,787,573
Less accumulated amortisation (540,841) (401,463)
Carrying amount 2,246,732 2,386,110
Cost
Balance at 1 July 2,787,573 2,787,573
Additions - -
Balance at 30 June 2,787,573 2,787,573
Accumulated amortisation
Balance at 1 July 401,463 262,084
Amortisation for the year 139,378 139,379
Balance at 30 June 540,841 401,463
Carrying amount at 30 June 2,246,732 2,386,110
Net carrying amount at 30 June 4,354,327 6,052,189
Intangible assets are stated at cost. The useful life of these patents and trademarks is estimated to be finite.
Impairments were recognised during the financial year with IP associated with patents that will not be renewed
were impaired by $1,901,552 (2025: $786,363).
CLEARVUE TECHNOLOGIES LIMITED AND ITS CONTROLLED ENTITIES
ABN 45 071 397 487
NOTES TO CONSOLIDATED PRELIMINARY FINANCIAL REPORT
FOR THE YEAR ENDED 30 JUNE 2026
7
5. TRADE AND OTHER PAYABLES
Consolidated
30 Jun 2026
$
Consolidated
30 Jun 2025
$
Trade payables 591,585 1,031,016
Prepaid revenue 181,222 246,614
Other payables 84,925 419,709
Accruals 364,639 314,618
1,222,371 2,011,957
6. SHARE CAPITAL
30-Jun-26 30-Jun-25 30-Jun-26 30-Jun-25
NO. OF
SHARES
NO. OF
SHARES
$ $
Share issued and fully paid
Balance at 1 July 268,625,167 242,658,474 51,349,503 41,021,685
Shares issued 67,743,973 23,437,500 9,460,365 7,500,000
Share based payments 2,966,040 454,193 469,240 88,278
ATM collateral shares issued 10,000,000 - - -
Options Exercised - 1,575,000 309,700 3,392,900
Performance rights exercised - 500,000 - -
Share issue costs - - (1,080,639) (653,360)
Balance at 30 June 349,335,180 268,625,167 60,508,169 51,349,503
The share capital of the Company consists only of fully paid ordinary shares; the shares do not have a par
value. All shares are equally eligible to receive dividends and the repayment of capital and represent one vote
at the shareholders’ meeting of the Company
CLEARVUE TECHNOLOGIES LIMITED AND ITS CONTROLLED ENTITIES
ABN 45 071 397 487
NOTES TO CONSOLIDATED PRELIMINARY FINANCIAL REPORT
FOR THE YEAR ENDED 30 JUNE 2026
8
7. SHARE-BASED PAYMENTS RESERVE
Consolidated 30
Jun 2026
Consolidated
30 Jun 2025
$ $
Opening balance 8,624,453 8,592,859
Performance Rights Issued 254,016 -
Options Issued 530,689 338,805
Options Exercised - (195,596)
Options expired (627,186) (76,162)
Share based payment - 99,410
Performance rights exercised - (134,863)
Performance rights lapsed (4,940,000) -
3,841,972 8,624,453
1The share plan arises on the grant of loan for a term of 10 years to Directors and related parties for the
purchase of the Company’s ordinary shares under the ClearVue Loan Funded Share Plan in 2017. Amounts
are transferred out of the reserve and into share capital when the loans are settled.
NO. OF
OPTIONS
NO. OF PERFORMANCE
RIGHTS
$
Movements in Share based
payment reserve
Balance at 1 July 2024 21,727,262 15,000,000 8,592,859
Options issued 1,150,000 - 338,805
Options exercised (1,575,000) - (195,596)
Options expired (1,550,000) - (76,162)
Options vested - - 99,410
Performance rights exercised - (500,000) (134,863)
Balance at 30 June 2025 19,752,262 14,500,000 8,624,449
NO. OF
OPTIONS
NO. OF PERFORMANCE
RIGHTS
$
Movements in Share based
payment reserve
Balance at 1 July 2025 19,752,262 14,500,000 8,624,449
Options issued 30,679,175 - 530,689
Options exercised - - -
Options expired (11,102,262) - (627,186)
Performance rights issued - 3,000,000 254,016
Performance rights expired - (13,500,000) (4,940,000)
Balance at 30 June 2026 39,929,175 4,000,000 3,841,972
CLEARVUE TECHNOLOGIES LIMITED AND ITS CONTROLLED ENTITIES
ABN 45 071 397 487
NOTES TO CONSOLIDATED PRELIMINARY FINANCIAL REPORT
FOR THE YEAR ENDED 30 JUNE 2026
9
7. SHARE-BASED PAYMENTS RESERVE – continued
Options
The following share-based payment arrangements were in place during the current and prior periods:
Class Number Grant date Expiry date Vesting Condition
CPVAT 1,150,000 05/07/2024 30/06/2027 No vesting Conditions
CPVAV 4,000,000 20/02/2026 20/02/2029 No vesting conditions
CPVAW 989,550 20/02/2026 20/02/2029 No vesting conditions
CPVAO3 500,000 30/10/2023 30/10/2027 Options vest on the condition the share price of
the Company reaches $0.50 and maintains a
VWAP of $0.50 for at least 14 days within and
prior to the expiry
CPVAP2 2,000,000 13/12/2023 13/12/2026 No vesting Conditions
CPVAQ2 2,000,000 13/12/2023 13/12/2026 No vesting conditions
CPVAU 25,689,625 20/02/2026 01/09/2026 No vesting conditions
CPVAM 3,000,000 20/06/2023 30/11/2026 No vesting conditions
CLEARVUE TECHNOLOGIES LIMITED AND ITS CONTROLLED ENTITIES
ABN 45 071 397 487
NOTES TO CONSOLIDATED PRELIMINARY FINANCIAL REPORT
FOR THE YEAR ENDED 30 JUNE 2026
10
7. SHARE-BASED PAYMENTS RESERVE – continued
The following table illustrates the number and weighted average exercise prices of and movements in share
options issued during the year:
2026 2025
Weighted
average
exercise price
Weighted
average
exercise price
Number $ Number $
Outstanding at the
beginning of year
19,752,262 0.56 21,727,262 0.52
Granted during the year 30,679,175 0.22 1,150,000 0.55
Exercised during the year - - (1,575,000) 0.21
Expired during the year (11,102,262) 0.54 (1,550,000) 0.30
Outstanding at the end of
year
39,329,175 0.30 19,752,262 0.56
Exercisable at the end of
year
39,329,175 0.30 12,752,262 0.58
The fair value of the equity-settled share options listed above is estimated as at the date of grant using the
Black-Scholes model taking into account the terms and conditions upon which the options were granted
The expected life of the options is based on historical data and is not necessarily indicative of exercise
patterns that may occur. The expected volatility reflects the assumption that the historical volatility is
indicative of future trends, which may also not necessarily be the actual outcome. No other features of
options granted were incorporated into the measurement of fair value
CLEARVUE TECHNOLOGIES LIMITED AND ITS CONTROLLED ENTITIES
ABN 45 071 397 487
NOTES TO CONSOLIDATED PRELIMINARY FINANCIAL REPORT
FOR THE YEAR ENDED 30 JUNE 2026
11
7. SHARE-BASED PAYMENTS RESERVE – continued
The conversion of the performance rights is dependent on the following:
(i) Class D Performance Rights
(A) In the event that the participant assisting the company completes the development and
testing of vision and spandrel glass to achieve an A2 SO D1 fire rating confirmed by an
independent third party testing, with such testing party approved by the company and
certified to the EN13501.1 standard before the expiry date, each class D performance
right will vest and be convertible into a share.
(ii) Class K Performance Rights
(A) In the event the 15 day volume weighted average price of the Company’s shares traded
on the Australian Securities Exchange being at least $0.30, each Class K Tranche A
Performance Right will vest and be convertible into a share.
(B) In the event the 15 day volume weighted average price of the Company’s shares traded
on the Australian Securities Exchange being at least $0.40, each Class K Tranche B
Performance Right will vest and be convertible into a share.
(C) In the event the 15 day volume weighted average price of the Company’s shares traded
on the Australian Securities Exchange being at least $0.60, each Class K Tranche C
Performance Right will vest and be convertible into a share.
(D) In the event the 15 day volume weighted average price of the Company’s shares traded
on the Australian Securities Exchange being at least $0.75, each Class K Tranche D
Performance Right will vest and be convertible into a share.
The fair value of the performance rights is estimated as at the date of grant using the Black-Scholes model
taking into account the terms and conditions upon which the rights were granted.
The performance requirements are non-vesting conditions as there is no service requirement and therefore
the fair value was expensed immediately.
8. SHARE-BASED PAY
Share your feedback
Discover